TipRanks on MSN
PepGen Inc. Advances DM1 Treatment with New Clinical Study
PepGen Inc. (($PEPG)) announced an update on their ongoing clinical study. PepGen Inc. has announced a new clinical study titled ‘An Open-Label ...
Mistry described Scp776 as a “designer drug.” She explained that IGF-1 receptors are abundant throughout the body, and IGF-1 ...
TipRanks on MSN
NRx Pharmaceuticals (NRXP) Advancing Two-Pronged Approach to Bring Innovative Therapies to Market
NRx Pharmaceuticals (NASDAQ: NRXP) was featured in a recent article that discussed its approach to bring preservative-free ...
After Hurricane Helene knocked out a North Carolina plant that supplies much of the IV fluid hospitals depend upon, MUSC ...
The position statement from cancer and bone societies updates recommendations from 2017 for managing bone loss and fracture ...
Marc, the son of Dolphins great Nick Buoniconti, went from a paralyzed college LB to an international spokesman for ...
A swanky $16m private wellness club offering the chance of a longer life and slowing the ageing process — and where ...
A collaborative research group has developed a novel therapeutic candidate that may improve the prognosis of severe cutaneous ...
Protein is having a moment. But even if most people are eating enough protein, studies suggest they may not be eating the right mix.
GSK may be happy with the latest readouts from two Hansoh-partnered antibody-drug conjugates, but the Big Pharma’s oncology R ...
The busiest death chamber in the country is located inside the maximum-security prison in Huntsville, Texas, known as the ...
Malnutrition is a common but difficult-to-manage complication for people with cancer, especially those treated with intensive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results